Results 211 to 220 of about 55,181 (252)
Some of the next articles are maybe not open access.

Immunodiagnosis of invasive fungal infection

Medical Mycology, 1992
Overview Invasive fungal infections are an important cause of morbidity and mortality, particularly in immunocompromised patients. The prognosis of these infections is poor unless they are diagnosed and treated promptly. Clinically, there is usually nothing specific to indicate a fungal infection and diagnosis depends on a combination of ...
Buckley, H R   +3 more
openaire   +3 more sources

Pathogenesis of invasive fungal infections

Current Opinion in Infectious Diseases, 2013
Invasive fungal infection (IFI) is increasingly being recognized as a significant cause of morbidity and mortality in immunosuppressed patients. This review focuses on the latest literature reports concerning the pathogenesis of IFI in this population.New virulence factors of Candida and Aspergillus have recently been identified.
Carolina, Garcia-Vidal   +2 more
openaire   +2 more sources

Immunomodulation of invasive fungal infections

Infectious Disease Clinics of North America, 2003
Genetic and acquired (disease- or therapy- related) host immune factors increase the risk for IFIs. In addition to antifungal drug therapy, modulation of host defenses by the use of HGFs and IFN-gamma has been supported by extensive in vitro and in vivo preclinical data.
Emmanuel, Roilides   +3 more
openaire   +2 more sources

Therapy of invasive fungal infections

The Netherlands Journal of Medicine, 1999
During the past decades, the incidence and severity of invasive fungal infections has been increasing. These events have lead to the development of new antifungal agents, and amphotericin B no longer is the standard therapy for a variety of invasive mycoses. Fluconazole has become the drug of choice for treatment of C.
Kullberg, B.J., Pauw, B.E. de
openaire   +3 more sources

The Challenge of Invasive Fungal Infection

Chemotherapy, 1999
Systemic fungal infections cause almost 25% of the infection-related deaths in leukaemic patients. Particularly those with prolonged neutropenia are at risk but mycoses also feature in critically ill intensive care patients and in individuals who are treated for solid tumours and AIDS, or who received an organ transplant.
B E, de Pauw, F, Meunier
openaire   +2 more sources

Immunodiagnosis of invasive fungal infections

Medical Mycology, 1994
(1994). Immunodiagnosis of invasive fungal infections. Journal of Medical and Veterinary Mycology: Vol. 32, No. sup1, pp. 239-252.
L, De Repentigny   +5 more
openaire   +2 more sources

Invasive Fungal Infections in the ICU

Journal of Intensive Care Medicine, 2009
Invasive fungal infections are major causes of morbidity and mortality in critically ill patients. Foremost among these is invasive candidiasis. In recent years, invasive aspergillosis (IA) and zygomycosis have emerged as major problems in susceptible, critically ill patients.
Shmuel, Shoham, Shilpa, Marwaha
openaire   +2 more sources

Overview of Invasive Fungal Infections

2012
The incidence of invasive fungal infections (IFIs) has seen a marked increase in the last two decades. This is especially evident among transplant recipients, patients suffering from AIDS, in addition to those in receipt of immunosuppressive therapy.
Nina L, Tuite, Katrina, Lacey
openaire   +2 more sources

Invasive Fungal Infections

Drugs, 2009
Invasive fungal infections (IFIs) are being increasingly recognized as a major threat in critically ill adult and paediatric patients. They can range widely in severity and can be life threatening in some patients. Candida and Aspergillus species are the most common causes of IFIs, but other yeasts and filamentous fungi are emerging pathogens.
openaire   +3 more sources

Clinical Experience in Invasive Fungal Infections

Clinical Drug Investigation, 2013
Lung infections caused by invasive filamentous fungi are very rare conditions in AIDS, but must be considered in patients with profound immune suppression especially in the presence of additional risk factors, such as hematologic malignancies, corticosteroid therapy, neutropenia, and chemotherapy. The authors report a case of dual lung infection caused
Pacheco, P   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy